Challenges and Barriers in the Ultomiris Drug Market: An In-depth...

ha aggiunto una foto Altre informazioni

2025-11-03 10:51:29 - Translate -

Challenges and Barriers in the Ultomiris Drug Market: An In-depth Analysis

Ultomiris Drug Market Overview Ultomiris (ravulizumab), developed by Alexion Pharmaceuticals (now part of AstraZeneca), is a next-generation complement inhibitor used primarily in the treatment of rare blood disorders such as Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), and Neuromyelitis Optica Spectrum Disorder...

0 Commenti 0 condivisioni 48 Views 0 Anteprima